Execs On The Move: Busy Week As Mettler-Toledo, Quotient, Vivasure And Others Appoint CEOs
Also this week, a large number of independent directors have joined companies such as SeaSpine Holdings, Biolidics and Integra LifeSciences.
You may also be interested in...
Myriad has sold several business units as it narrows its focus to oncology, women's health and mental health diagnostics. CEO Paul Diaz says the moves will allow the company to be a market leader.
US FDA’s Accelerated Approval process has always been a deceptively simple idea. After a three-day public review of ‘dangling’ applications, the underlying complexity remains.
Merck has pulled one Accelerated Approval indication for Keytruda already this year, and a second may have to be withdrawn as well. That will leave the product with 27 indications in the US – unless, of course, more are approved before the AA indications are formally pulled.